2018 Journal Article ReplyStaudacher, Heidi M. and Whelan, Kevin (2018). Reply. Gastroenterology, 154 (5), 1548-1548. doi: 10.1053/j.gastro.2018.03.016 |
2018 Journal Article Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biasesGray, Marcus A., Chao, Che-Yung, Staudacher, Heidi M., Kolosky, Natasha A., Talley, Nicholas J. and Holtmann, Gerald (2018). Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases. PLoS One, 13 (3) e0193542, e0193542. doi: 10.1371/journal.pone.0193542 |
2018 Journal Article Nutritional implications of dietary interventions for managing gastrointestinal disordersStaudacher, Heidi M., Kurien, Matthew and Whelan, Kevin (2018). Nutritional implications of dietary interventions for managing gastrointestinal disorders. Current Opinion in Gastroenterology, 34 (2), 105-111. doi: 10.1097/MOG.0000000000000421 |
2018 Journal Article The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practiceWhelan, K., Martin, L. D., Staudacher, H. M. and Lomer, M. C. E. (2018). The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. Journal of Human Nutrition and Dietetics, 31 (2), 239-255. doi: 10.1111/jhn.12530 |
2018 Journal Article Long term impact of the low FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability and healthcare utilisation in irritable bowel syndromeO'Keeffe, M., Jansen, C., Martin, L., Williams, M., Seamark, L., Staudacher, H. M., Irving, P. M., Whelan, K. and Lomer, M. C. (2018). Long term impact of the low FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability and healthcare utilisation in irritable bowel syndrome. Neurogastroenterology and Motility, 30 (1) e13154, e13154. doi: 10.1111/nmo.13154 |
2017 Journal Article The challenges of control groups, placebos and blinding in clinical trials of dietary interventionsStaudacher, Heidi M, Irving, Peter M, Lomer, Miranda C E and Whelans, Kevin (2017). The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. The Proceedings of the Nutrition Society, 76 (4), 628-628. doi: 10.1017/S0029665117002816 |
2017 Journal Article Volatile organic compounds as predictors of response to dietary intervention in irritable bowel syndromeRossi, Megan, Aggio, Raphael, Staudacher, Heidi M., Lomer, Miranda C., Lindsay, James O., Irving, Peter, Probert, Chris and Whelan, Kevin (2017). Volatile organic compounds as predictors of response to dietary intervention in irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 16 (3), 385-391. doi: 10.1016/j.cgh.2017.09.055 |
2017 Journal Article A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores bifidobacterium species: a randomized controlled trialStaudacher, Heidi Maria, Lomer, Miranda C. E., Farquharson, Freda M., Louis, Petra, Fava, Francesca, Franciosi, Elena, Scholz, Matthias, Tuohy, Kieran M., Lindsay, James O., Irving, Peter M. and Whelan, Kevin (2017). A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores bifidobacterium species: a randomized controlled trial. Gastroenterology, 153 (4), 936-947. doi: 10.1053/j.gastro.2017.06.010 |
2017 Journal Article The low FODMAP diet: recent advances in understandings its mechanisms and efficacy in IBSStaudacher, Heidi M. and Whelan, Kevin (2017). The low FODMAP diet: recent advances in understandings its mechanisms and efficacy in IBS. Gut, 66 (8), 1517-1527. doi: 10.1136/gutjnl-2017-313750 |
2017 Journal Article Editorial: metabolic adaptation of colonic microbiota to galactooligosaccharides - good news for prebiotics in irritable bowel syndrome?Staudacher, H. M. and Cox, S. R. (2017). Editorial: metabolic adaptation of colonic microbiota to galactooligosaccharides - good news for prebiotics in irritable bowel syndrome?. Alimentary Pharmacology and Therapeutics, 45 (7), 1005-1006. doi: 10.1111/apt.13976 |
2017 Journal Article Nutritional, microbiological and psychosocial implications of the low FODMAP dietStaudacher, Heidi Maria (2017). Nutritional, microbiological and psychosocial implications of the low FODMAP diet. Journal Gastroenterology and Hepatology, 32 (S1), 16-19. doi: 10.1111/jgh.13688 |
2015 Journal Article Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndromeWhigham, L., Joyce, T., Harper, G., Irving, P. M., Staudacher, H. M., Whelan, K. and Lomer, M. C. E. (2015). Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. Journal of Human Nutrition and Dietetics, 28 (6), 687-696. doi: 10.1111/jhn.12318 |
2015 Journal Article How healthy is a gluten-free diet?Staudacher, Heidi M. and Gibson, Peter R. (2015). How healthy is a gluten-free diet?. British Journal of Nutrition, 114 (10), 1539-1541. doi: 10.1017/S000711451500330X |
2015 Journal Article Probiotics for lactose intolerance and irritable bowel syndromeStaudacher, Heidi (2015). Probiotics for lactose intolerance and irritable bowel syndrome. British journal of community nursing, 20 (S1), S13-S14. doi: 10.12968/bjcn.2015.20.Sup6a.S12 |
2014 Journal Article Mechanisms and efficacy of dietary FODMAP restriction in IBSStaudacher, Heidi M., Irving, Peter M., Lomer, Miranda C. E. and Whelan, Kevin (2014). Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nature Reviews Gastroenterology & Hepatology, 11 (4), 256-266. doi: 10.1038/nrgastro.2013.259 |
2012 Journal Article Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndromeStaudacher, Heidi M., Lomer, Miranda C. E., Anderson, Jacqueline L., Barrett, Jacqueline S., Muir, Jane G., Irving, Peter M. and Whelan, Kevin (2012). Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. Journal of Nutrition, 142 (8), 1510-1518. doi: 10.3945/jn.112.159285 |
2011 Journal Article Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndromeStaudacher, H. M., Whelan, K., Irving, P. M. and Lomer, M. C. E. (2011). Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. Journal of Human Nutrition and Dietetics, 24 (5), 487-495. doi: 10.1111/j.1365-277X.2011.01162.x |
2011 Journal Article Fructan content of commonly consumed wheat, rye and gluten-free breadsWhelan, Kevin, Abrahmsohn, Olivia, David, Gondi J. P., Staudacher, Heidi, Irving, Peter, Lomer, Miranda C. E. and Ellis, Peter R. (2011). Fructan content of commonly consumed wheat, rye and gluten-free breads. International Journal of Food Sciences and Nutrition, 62 (5), 498-503. doi: 10.3109/09637486.2011.553588 |
2002 Journal Article Effect of short-term fat adaptation on high-intensity trainingStepto, Nigel K., Carey, Andrew L., Staudacher, Heidi M., Cummings, Nicola K., Burke, Louise M. and Hawley, John A. (2002). Effect of short-term fat adaptation on high-intensity training. Medicine and Science in Sports and Exercise, 34 (3), 449-55. |
2001 Journal Article Short-term high-fat diet alters substrate utilization during exercise but not glucose tolerance in highly trained athletesStaudacher, H. M., Carey, A. L., Cummings, N. K., Hawley, J. A. and Burke, L. M. (2001). Short-term high-fat diet alters substrate utilization during exercise but not glucose tolerance in highly trained athletes. International Journal of Sport Nutrition and Exercise Metabolism, 11 (3), 273-286. |